Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Translational Neurodegeneration
Published in: Translational Neurodegeneration 1/2017

Open Access 01-12-2017 | Research

Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosis

Authors: Gary Leung, Melissa Tully, Jonathan Tang, Shengxi Wu, Riyi Shi

Published in: Translational Neurodegeneration | Issue 1/2017

Login to get access

Abstract

Background

It is increasingly clear that in addition to myelin disruption, axonal degeneration may also represent a key pathology in multiple sclerosis (MS). Hence, elucidating the mechanisms of axonal degeneration may not only enhance our understanding of the overall MS pathology, but also elucidate additional therapeutic targets. The objective of this study is assess the degree of axonal membrane disruption and its significance in motor deficits in EAE mice.

Methods

Experimental Autoimmune Encephalomyelitis was induced in mice by subcutaneous injection of myelin oligodendrocyte glycoprotein/complete Freud’s adjuvant emulsion, followed by two intraperitoneal injections of pertussis toxin. Behavioral assessment was performed using a 5-point scale. Horseradish Peroxidase Exclusion test was used to quantify the disruption of axonal membrane. Polyethylene glycol was prepared as a 30% (w/v) solution in phosphate buffered saline and injected intraperitoneally.

Results

We have found evidence of axonal membrane disruption in EAE mice when symptoms peak and to a lesser degree, in the pre-symptomatic stage of EAE mice. Furthermore, polyethylene glycol (PEG), a known membrane fusogen, significantly reduces axonal membrane disruption in EAE mice. Such PEG-mediated membrane repair was accompanied by significant amelioration of behavioral deficits, including a delay in the emergence of motor deficits, a delay of the emergence of peak symptom, and a reduction in the severity of peak symptom.

Conclusions

The current study is the first indication that axonal membrane disruption may be an important part of the pathology in EAE mice and may underlies behavioral deficits. Our study also presents the initial observation that PEG may be a therapeutic agent that can repair axolemma, arrest axonal degeneration and reduce motor deficits in EAE mice.
Literature
1.
2.
Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain. 2006;129:1953–71.CrossRefPubMed
3.
Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–69.CrossRefPubMed
4.
Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology. 2007;68:S22–31. discussion S43-54.CrossRefPubMed
5.
Tully M, Shi R. New insights in the pathogenesis of multiple sclerosis—role of acrolein in neuronal and myelin damage. Int J Mol Sci. 2013;14:20037–47.CrossRefPubMedPubMedCentral
6.
Stadelmann C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol. 2011;24:224–9.CrossRefPubMed
7.
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175–89.CrossRefPubMedPubMedCentral
8.
Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, Kovacs GG, Kutzelnigg A, Lassmann H, Frischer JM. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014;85:1386–95.CrossRefPubMedPubMedCentral
9.
Kandel ER, Schwartz JH, Jessell TM. Principles of neural science. 4th ed. New York: McGraw-cbrhill; 2000.
10.
Shi Y, Sun W, McBride JJ, Cheng JX, Shi R. Acrolein induces myelin damage in mammalian spinal cord. J Neurochem. 2011;117:554–64.CrossRefPubMed
11.
Shi R, Whitebone J. Conduction deficits and membrane disruption of spinal cord axons as a function of magnitude and rate of strain. J Neurophysiol. 2006;95:3384–90.CrossRefPubMed
12.
Ouyang H, Sun W, Fu Y, Li J, Cheng JX, Nauman E, Shi R. Compression induces acute demyelination and potassium channel exposure in spinal cord. J Neurotrauma. 2010;27:1109–20.CrossRefPubMedPubMedCentral
13.
Hendricks BK, Shi R. Mechanisms of neuronal membrane sealing following mechanical trauma. Neurosci Bull. 2014;30:627–44.CrossRefPubMed
14.
Charil A, Filippi M. Inflammatory demyelination and neurodegeneration in early multiple sclerosis. J Neurol Sci. 2007;259:7–15.CrossRefPubMed
15.
Shi R. The dynamics of axolemmal disruption in guinea pig spinal cord following compression. J Neurocytol. 2004;33:203–11.CrossRefPubMed
16.
Shi R, Pryor JD. Pathological changes of isolated spinal cord axons in response to mechanical stretch. Neuroscience. 2002;110:765–77.CrossRefPubMed
17.
Shi R, Asano T, Vining NC, Blight AR. Control of membrane sealing in injured mammalian spinal cord axons. J Neurophysiol. 2000;84:1763–9.PubMed
18.
Shi R, Luo J, Peasley MA. Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea pig spinal cord. Neuroscience. 2002;115:337–40.CrossRefPubMed
19.
Luo J, Shi R. Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol. Neurosci Lett. 2004;359:167–70.CrossRefPubMed
20.
Liu-Snyder P, McNally H, Shi R, Borgens RB. Acrolein-mediated mechanisms of neuronal death. J Neurosci Res. 2006;84:209–18.CrossRefPubMed
21.
Hamann K, Durkes A, Ouyang H, Uchida K, Pond A, Shi R. Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J Neurochem. 2008;107:712–21.CrossRefPubMedPubMedCentral
22.
Hamann K, Nehrt G, Ouyang H, Duerstock B, Shi R. Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J Neurochem. 2008;104:708–18.PubMed
23.
24.
Yan R, Page JC, Shi R. Acrolein-mediated conduction loss is partially restored by K+ channel blockers. J Neurophysiol. 2016;115:701–10.CrossRefPubMed
25.
Leung G, Sun W, Zheng L, Brookes S, Tully M, Shi R. Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse. Neuroscience. 2011;173:150–5.CrossRefPubMed
26.
Luo J, Borgens R, Shi R. Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J Neurochem. 2002;83:471–80.CrossRefPubMed
27.
Luo J, Borgens R, Shi R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma. 2004;21:994–1007.CrossRefPubMed
28.
Shi R, Borgens RB. Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J Neurophysiol. 1999;81:2406–14.PubMed
29.
Nehrt A, Hamann K, Ouyang H, Shi R. Polyethylene glycol enhances axolemmal resealing following transection in cultured cells and in ex vivo spinal cord. J Neurotrauma. 2010;27:151–61.CrossRefPubMed
30.
Shi R, Borgens RB. Anatomical repair of nerve membranes in crushed mammalian spinal cord with polyethylene glycol. J Neurocytol. 2000;29:633–43.CrossRefPubMed
31.
Borgens RB, Shi R. Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. Faseb J. 2000;14:27–35.PubMed
32.
Shi R. Polyethylene glycol repairs membrane damage and enhances functional recovery: a tissue engineering approach to spinal cord injury. Neurosci Bull. 2013;29:460–6.CrossRefPubMed
33.
Shi Y, Kim S, Huff TB, Borgens RB, Park K, Shi R, Cheng JX. Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nat Nanotechnol. 2010;5:80–7.CrossRefPubMed
34.
Baptiste DC, Austin JW, Zhao W, Nahirny A, Sugita S, Fehlings MG. Systemic polyethylene glycol promotes neurological recovery and tissue sparing in rats after cervical spinal cord injury. J Neuropathol Exp Neurol. 2009;68:661–76.CrossRefPubMed
35.
Luo J, Shi R. Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res. 2007;1155:10–6.CrossRefPubMed
36.
Liu-Snyder P, Logan MP, Shi R, Smith DT, Borgens RB. Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J Exp Biol. 2007;210:1455–62.CrossRefPubMed
37.
Ditor DS, John SM, Roy J, Marx JC, Kittmer C, Weaver LC. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res. 2007;85:1458–67.CrossRefPubMed
38.
Detloff MR, Lavik E, Fisher LC, Langer R, Basso DM. Polyethylene glycol administration after moderate spinal cord injury decreases lesionsize and improves locomotor recovery. J Neurotrauma. 2005;22:1219.
39.
Duerstock BS, Borgens RB. Three-dimentional morphometry of spinal cord injury follow polyethylene glycol treatment. J Exp Biol. 2002;205:13–24.PubMed
40.
Borgens RB, Shi R, Bohnert D. Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J Exp Biol. 2002;205:1–12.PubMed
41.
Kalyvas A, David S. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron. 2004;41:323–35.CrossRefPubMed
42.
Shi R, Pryor JD. Temperature dependence of membrane sealing following transection in mammalian spinal cord axons. Neuroscince. 2000;98:157–66.CrossRef
43.
Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology. 2001;57:1248–52.CrossRefPubMed
44.
Schanne FAX, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: a final common pathway. Science. 1979;206:700–2.CrossRefPubMed
45.
Xie X, Barrett JN. Membrane resealing in cultured rat septal neurons after neurite transection: evidence for enhancement by Ca2 + −triggered protease activity and cytoskeletal disassembly. J Neurosci. 1991;11:3257–67.PubMed
46.
47.
Chen H, Quick E, Leung G, Hamann K, Fu Y, Cheng JX, Shi R. Polyethylene glycol protects injured neuronal mitochondria. Pathobiology. 2009;76:117–28.CrossRefPubMed
48.
Borgens RB, Bohnert D. Rapid recovery from spinal cord injury following subcutaneously administered polyethylene glycol. J Neurosci Res. 2001;66:1179–86.CrossRefPubMed
49.
Luo J, Shi R. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem Int. 2004;44:475–86.CrossRefPubMed
50.
Hamann K, Shi R. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem. 2009;111:1348–56.CrossRefPubMed
51.
Liu-Snyder P, Borgens RB, Shi R. Hydralazine rescues PC12 cells from acrolein-mediated death. J Neurosci Res. 2006;84:219–27.CrossRefPubMed
52.
Shi R, Luo L. The role of acrolein in spinal cord injury. Appl Neurol. 2006;2:22–7.
53.
Park J, Zheng L, Marquis A, Walls M, Duerstock B, Pond A, Vega-Alvarez S, Wang H, Ouyang Z, Shi R. Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage. J Neurochem. 2014;129:339–49.CrossRefPubMed
54.
Park J, Muratori B, Shi R. Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury. Neural Regen Res. 2014;9:677–83.CrossRefPubMedPubMedCentral
55.
Shi R, Sun W. Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons. Neurosci Bull. 2011;27:36–44.CrossRefPubMed
56.
Leung G, Sun W, Brookes S, Smith D, Shi R. Potassium channel blocker, 4-Aminopyridine-3-Methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis. Exp Neurol. 2011;227:232–5.CrossRefPubMed
57.
Metadata
Title
Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosis
Authors
Gary Leung
Melissa Tully
Jonathan Tang
Shengxi Wu
Riyi Shi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2017
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-017-0075-7

Other articles of this Issue 1/2017

Translational Neurodegeneration 1/2017 Go to the issue

Review

RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA

Research

Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

Review

Rest tremor revisited: Parkinson’s disease and other disorders

Review

Role of BACE1 in Alzheimer’s synaptic function

Review

Effect of low versus high frequency stimulation on freezing of gait and other axial symptoms in Parkinson patients with bilateral STN DBS: a mini-review

Research

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)